AIHTA - Publications - Search - Brigatinib (Alunbrig®) in ALK-positive non–small-cell lung cancer (NSCLC)

Grössmann, N. (2020): Brigatinib (Alunbrig®) in ALK-positive non–small-cell lung cancer (NSCLC). Oncology Fact Sheet Nr. 4.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
41Kb

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WF Respiratory system
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:Oncology Fact Sheet Nr. 4
Deposited on:01 Apr 2020 12:15
Last Modified:02 Jun 2020 18:35

Repository Staff Only: item control page